141 related articles for article (PubMed ID: 14735690)
1. Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.
Chiou JF; Lin MC; Chen DR; Jim YF; Kao CH
Cancer Invest; 2003; 21(6):863-8. PubMed ID: 14735690
[TBL] [Abstract][Full Text] [Related]
2. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
3. Comparing thallium-201 spect mammoscintigraphy and ultrasonography to detect breast cancer in mammographical dense breasts.
Chen DR; Jeng LB; Kao A; Lin CC; Lee CC
Neoplasma; 2003; 50(3):222-6. PubMed ID: 12937857
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
5. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of mammoscintigraphy with thallium-201 single photon emission computed tomography to differentiate palpable breast masses of young Taiwanese women when comparing with mammography.
Chen DR; Jeng LB; Kao A; Lin CC; Lee CC
Neoplasma; 2002; 49(5):334-7. PubMed ID: 12458333
[TBL] [Abstract][Full Text] [Related]
7. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.
Wang HC; Sun SS; Kao A; Lin CC; Lee CC
Cancer Invest; 2002; 20(3):318-23. PubMed ID: 12025226
[TBL] [Abstract][Full Text] [Related]
8. Detecting breast cancer in mammographically dense breasts: comparing technetium-99m tetrofosmin mammoscintigraphy and ultrasonography.
Wang HC; Chen DR; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(7-8):932-8. PubMed ID: 12449724
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
10. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
11. Tl-201 scintigraphy, mammography and ultrasonography in the evaluation of palpable and nonpalpable breast lesions: a correlative study.
Ozdemir A; Oznur II; Vural G; Atasever T; Karabacak NI; Gökçora N; Işik S; Unlü M
Eur J Radiol; 1997 Feb; 24(2):145-54. PubMed ID: 9097057
[TBL] [Abstract][Full Text] [Related]
12. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of palpable breast masses with 201Tl scintigraphy.
Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A
Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m Sestamibi Scintimammography for the Evaluation of Breast Masses in Patients with Radiographically Dense Breasts.
Cutrone JA; Khalkhali I; Yospur LS; Diggles L; Weinberg I; Pong EM; Tolmos J; Vargas MP; Vargas HI
Breast J; 1999 Nov; 5(6):383-388. PubMed ID: 11348318
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
Lee JK; Kao CH; Sun SS
Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
[TBL] [Abstract][Full Text] [Related]
19. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy.
Carril JM; Gómez-Barquín R; Quirce R; Tabuenca O; Uriarte I; Montero A
Anticancer Res; 1997; 17(3B):1677-81. PubMed ID: 9179217
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
